Skip to main content
. 2023 Mar 16;14:1164926. doi: 10.3389/fphys.2023.1164926

TABLE 1.

Main patient characteristics.

Group Pat ID Age Gender Diagnosis Operation POD PRBC storage duration (d) PRBCs transfused during surgery (n) Total PRBCs at ICU (n)
Aorta 34 65 m Peripheral arterial vascular disease Axillofemoral bypass 1 11 2 2
36 77 m Abdominal aortic aneurysm Bifemoral prothesis 2 24 0 2
48 82 f Abdominal aortic aneurysm Bi-iliacal prothesis 1 17 3 4
81 81 m Abdominal aortic aneurysm Aortic replacement 2 29 1 4
LuTx 10 65 m Fibrosis LuTx 3 25 5 34
12 32 f Idiopathic pulmonary hypertension LuTx 1 23 9 6
14 59 f Chronic obstructive pulmonary disease LuTx 3 36 2 1
15 38 m Cystic fibrosis, transplant dysfunction Re-LuTx 3 31 7 2
25 25 f Cystic fibrosis LuTx 3 29 10 1
49 48 m Cystic fibrosis, transplant dysfunction Re-LuTx 8 18 22 5
64 37 m Fibrosis LuTx 6 23 17 5
73 33 m Cystic fibrosis LuTx 3 20 5 2
Comparison 17 36 m Abdominal wall seroma Multiple 5 22 7 6
20 84 m Neoplasma vesicae Cystectomy 3 25 0 1
43 56 m Pericardial effusion Pericardial drainage 4 33 0 17
46 77 m Status post subhepatic hematoma Wound management 1 29 0 6
61 59 m Thymoma Thymectomy 44 18 13 20
68 59 m Renal cell carcinoma Partial nephrectomy 1 17 3 5
79 72 f Stomach perforation Gastrectomy 1 13 1 1
80 62 m Neoplasma vesicae Cystectomy 1 25 0 2
87 59 m Peripheral arterial vascular disease Thrombectomy 2 20 0 3

Pat ID, patient identification number; PRBC, packed red blood cell; POD, postoperative day at time point of transfusion; d, days; ICU, intensive care unit; LuTx, bilateral lung transplantation; Re-LuTx; repeated bilateral lung transplantation; m, male; f, female.